
Paroxysmal nocturnal hemoglobinuria drug Empaveli targets extravasation hemolysis
The paroxysmal nocturnal hemoglobinuria (PNH) drug Empaveli (pegcetacoplan), introduced in Korea last year and currently covered by health insurance, has been confirmed as a treatment option for the unmet medical need of extravascular hemolysis. Handok, …